Commercialization Best Practices from Small and Mid-sized Pharma (Part 1)

Issues like health policy changes and industry consolidation have impacted the entire pharmaceutical market, but small and mid-sized pharmaceutical companies have responded to these issues in a different-and often more nimble-way. Doug Cook, vice president of operations for ICS, joins In the Know to explore the unique mindset that many smaller pharmaceutical companies have as they approach commercialization decisions around logistics, regulatory compliance and data requirements. He also discusses what larger manufacturers might learn from small pharma's best practices.

Category:

Science & Technology

Tags:

• ABSG
• AmerisourceBergen
• Specialty
• Group
• In
• the
• Know
• ICS
• Commercialization
• Pharma